Incorporation of liver chemistry score in predicting survival of liver‐involved advanced gastric cancer patients who received palliative chemotherapy-Reference-Cited by-同舟云学术

Incorporation of liver chemistry score in predicting survival of liver‐involved advanced gastric cancer patients who received palliative chemotherapy

Published:2022-09-04 Issue:3 Volume:12 Page:2831-2841
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Feng Ying¹^ORCID,Zhang Cheng¹²^ORCID,Wu Zhijun³^ORCID,Xu Hui¹²^ORCID,Zhang Xiaopeng⁴^ORCID,Feng Chong⁴^ORCID,Shao Jingyi¹^ORCID,Xie Minmin¹^ORCID,Yang Yahui¹^ORCID,Zhang Yi¹^ORCID,Ma Tai¹^ORCID

Affiliation:

1. Department of Oncology The First Affiliated Hospital of Anhui Medical University Hefei People's Republic of China

2. Anhui Provincial Cancer Institute/Anhui Provincial Office for Cancer Prevention and Control Hefei People's Republic of China

3. Department of Oncology Ma'anshan Municipal People's Hospital Ma'anshan People's Republic of China

4. Department of Noncommunicable Diseases and Health Education Hefei Center for Disease Control and Prevention Hefei People's Republic of China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5179

Reference27 articles.

1. Stomach cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study

2. The survival and the long-term trends of patients with gastric cancer in Shanghai, China

3. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

4. Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS Trial

5. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A bibliometric analysis of gastric cancer liver metastases: advances in mechanisms of occurrence and treatment options;International Journal of Surgery;2024-01-11

2. Bone metastasis is a late-onset and unfavorable event in survivors of gastric cancer after radical gastrectomy: Results from a clinical observational cohort;Cancer Pathogenesis and Therapy;2024-01

3. Survival prediction in advanced cancer patients – a narrative review;Current Opinion in Supportive & Palliative Care;2023-04-06

4. Hepatocellular carcinoma cells loss lenvatinib efficacy in vitro through autophagy and hypoxia response-derived neuropilin-1 degradation;Acta Pharmacologica Sinica;2022-11-14